Our manuscript showing that CX-5461 acts through Topoisomerase II and creates collateral resistance to canonical Topoisomerase II poisons was just accepted at PNAS. This was a Terrific collaboration with Peter Bruno (Elledge Lab @ Harvard Med) and Michael Hemann (Koch Institute @ MIT). Manuscript is currently under embargo!